Document is current
Any future updates will be listed below
-
Authors
Maglaperidze, Tatia
Zurashvili, Tamar
DeHovitz, Jack
Tukvadze, Nestani
Djibuti, Mamuka
-
Funding
Funding for this research was provided by:
Fogarty International Center and the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health (D43 TW011532)
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 16 October 2025
First Online: 12 November 2025
Declarations
:
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. Ethical approval for the study was obtained from the Institutional Review Board (IRB) of the National Center for Disease Control and Public Health of Georgia (IRB# 2025-007). The IRB reviewed and approved the study protocol titled “Improving HIV/HCV/TB Integrated Screening Among High-Risk Populations at Primary Healthcare Facilities in Georgia.” The approval is valid from February 7, 2025, to February 7, 2026. All necessary precautions were taken to ensure the confidentiality and well-being of participants. Informed consent was obtained from all participants prior to their inclusion in the study.
: Not applicable. This study does not include any individual-level identifying images or personal or clinical details of participants that compromise anonymity.
: The authors declare no competing interests.
